Get the Stockscreener App
9.40
5.43%
-0.54
After Hours:
9.40
Neuropace Inc stock is traded at $9.40, with a volume of 233.48K.
It is down -5.43% in the last 24 hours and down -13.92% over the past month.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
See More
Previous Close:
$9.94
Open:
$9.88
24h Volume:
233.48K
Relative Volume:
1.37
Market Cap:
$310.97M
Revenue:
$65.42M
Net Income/Loss:
$-32.96M
P/E Ratio:
-7.4016
EPS:
-1.27
Net Cash Flow:
$-19.87M
1W Performance:
-11.32%
1M Performance:
-13.92%
6M Performance:
-21.54%
1Y Performance:
+49.44%
1-Day Range:
$9.22
$9.88
1-Week Range:
$9.22
$10.81
52-Week Range:
$6.03
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Name
Neuropace Inc
Sector
Industry
Phone
(650) 237-2700
Address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Compare NPCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
9.40 | 328.83M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | H.C. Wainwright | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Mar-14-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Initiated | Leerink Partners | Outperform |
| Nov-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-24-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-22-23 | Initiated | Lake Street | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-19-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-11-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-18-21 | Initiated | Robert W. Baird | Outperform |
| May-17-21 | Initiated | JP Morgan | Overweight |
| May-17-21 | Initiated | Morgan Stanley | Overweight |
| May-17-21 | Initiated | SVB Leerink | Outperform |
| May-17-21 | Initiated | Wells Fargo | Overweight |
View All
Neuropace Inc Stock (NPCE) Latest News
Real time alert setup for NeuroPace Inc. performance2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Why NeuroPace Inc. stock is a value investor pickSwing Trade & Safe Investment Capital Preservation Plans - newser.com
How to escape a deep drawdown in NeuroPace Inc.Earnings Recap Summary & Daily Stock Momentum Reports - newser.com
NeuroPace Inc (NPCE) Q3 2025 Earnings Report Preview: What to Look For - Yahoo Finance
Using data tools to time your NeuroPace Inc. exitJuly 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com
Evaluating NeuroPace Inc. with trendline analysis2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
What technical signals suggest for NeuroPace Inc. stockMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
What is the fair value of NeuroPace Inc. stock nowJuly 2025 Breakouts & Reliable Volume Spike Alerts - newser.com
Will NeuroPace Inc. price bounce be sustainableMarket Risk Report & AI Enhanced Execution Alerts - newser.com
Using RSI to spot recovery in NeuroPace Inc.CPI Data & Stock Market Timing Techniques - newser.com
Why NeuroPace Inc. stock is seen as undervaluedWeekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
Can NeuroPace Inc. stock sustain revenue growthJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
Will NeuroPace Inc. stock recover faster than marketJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
Tools to assess NeuroPace Inc.’s risk profilePortfolio Performance Report & Consistent Profit Focused Trading Strategies - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Operating expenses (excl. COGS) of Neuropace, Inc. – BOATS:NPCE - TradingView
NeuroPace Inc. stock outlook for YEARTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Can NeuroPace Inc. stock withstand economic slowdown2025 Valuation Update & High Yield Stock Recommendations - newser.com
Applying Elliott Wave Theory to NeuroPace Inc.Market Trend Summary & Consistent Profit Trade Alerts - newser.com
Will NeuroPace Inc. stock gain from government policiesMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
Does NeuroPace Inc. fit your quant trading modelJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Neuropace Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Neuropace, Inc. (NPCE) Stock forecasts - Yahoo! Finance UK
Strategies to average down on NeuroPace Inc.Portfolio Profit Report & Smart Allocation Stock Tips - newser.com
Can NeuroPace Inc. stock resist market sell offsJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Can momentum traders help lift NeuroPace Inc.Market Sentiment Review & Technical Entry and Exit Alerts - newser.com
NeuroPace, Inc. Reports Record Revenue and Strong Margins in Q2 2025 Earnings Call - MSN
Neuropace Inc Stock (NPCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuropace Inc Stock (NPCE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER |
Feb 21 '25 |
Sale |
13.72 |
78,334 |
1,074,844 |
81,993 |
| KCK LTD. | 10% Owner |
Feb 20 '25 |
Sale |
9.40 |
5,270,845 |
49,545,943 |
0 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 30 '25 |
Sale |
15.00 |
200 |
3,000 |
86,762 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 29 '25 |
Sale |
15.00 |
100 |
1,500 |
86,962 |
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):